Zobrazeno 1 - 6
of 6
pro vyhledávání: '"S. P. G. van Vugt"'
Autor:
Jos Thannhauser, Rypko Beukema, Marc A. Brouwer, Martin E.W. Hemels, S. P. G. van Vugt, Sjoerd W. Westra, G B Chierchia, Rick H J A Volleberg, Reinder Evertz, C De Asmundis
Publikováno v:
European Heart Journal. 40
Background Strategies to detect recurrences after atrial fibrillation (AF) catheter ablation vary widely. Whereas a symptom-based approach may overestimate procedural success due to asymptomatic recurrences, continuous invasive monitoring with implan
Autor:
L. M. Bloem-de Vries, M. T. H. Albers-Akkers, E. J. P. Lamfers, Freek W.A. Verheugt, Marc A. Brouwer, J. Jaspers Focks, S. P. G. van Vugt
Publikováno v:
Journal of Thrombosis and Haemostasis. 14:1715-1724
Essentials Under-treatment of oral anticoagulation in the elderly with atrial fibrillation is common. As bleeding prediction is challenging, we compared HAS-BLED, ATRIA and HEMORR2HAGES. All three were associated with major bleeding in the elderly, b
Autor:
J. Jaspers Focks, Cornelis Kramers, S. P. G. van Vugt, M.J. de Boer, Brouwer, E. J. P. Lamfers, Freek W.A. Verheugt, L. M. Bloem-de Vries, Goaris W.A. Aarts
Publikováno v:
European Cardiology, 15
European Cardiology Review, Vol 15, Iss, Pp e46-(2020)
European Cardiology Review
European Cardiology Review, Vol 15, Iss, Pp e46-(2020)
European Cardiology Review
Contains fulltext : 220890.pdf (Publisher’s version ) (Open Access)
Autor:
S. P. G. van Vugt, Marc A. Brouwer
Publikováno v:
Netherlands Heart Journal
In this manuscript, we discuss the most important changes in the field of anticoagulant treatment in patients with atrial fibrillation in the setting of electrical cardioversion or catheter ablation. Moreover, we provide practical guidance as well as
Autor:
Marc A. Brouwer, Ron Pisters, Martin E.W. Hemels, Harry J.G.M. Crijns, P. A. G. Zwart, W. L. ten Holt, S. P. G. van Vugt, Paulus Kirchhof, Arif Elvan
Publikováno v:
Netherlands Heart Journal, 25, 551-558
Netherlands Heart Journal, 25(10), 551-558. Bohn Stafleu van Loghum
Netherlands Heart Journal, 25, 10, pp. 551-558
Netherlands Heart Journal
Netherlands Heart Journal, 25(10), 551-558. Bohn Stafleu van Loghum
Netherlands Heart Journal, 25, 10, pp. 551-558
Netherlands Heart Journal
Background The Xarelto for Prevention of Stroke in Patients with Atrial Fibrillation (XANTUS) registry investigated the safety and efficacy of the factor Xa inhibitor rivaroxaban. We studied the Dutch XANTUS cohort to a ssess drug safety and prescrip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a8e60836bc59705cee827703eac538c
http://hdl.handle.net/2066/179607
http://hdl.handle.net/2066/179607
Autor:
Sjoerd W. Westra, Reinder Evertz, S. P. G. van Vugt, Sümeyye Sezer, Joep L.R.M. Smeets, Marc A. Brouwer, Rypko Beukema, Gian-Battista Chierchia, Martin E.W. Hemels
Publikováno v:
JACC: Clinical Electrophysiology. 3:S9-S10
The ideal energy source and strategy for repeat ablation procedures of atrial fibrillation (AF) has to be established. Data on redo procedures using cryoballoon technique are limited. We report long-term follow-up on cryoballoon redo procedures after